keyword
https://read.qxmd.com/read/38643439/impaired-fibrinolysis-in-patients-with-atrial-fibrillation-and-elevated-circulating-lipopolysaccharide
#1
JOURNAL ARTICLE
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
It is unknown whether elevated gut-derived serum lipopolysaccharide (LPS) can affect thrombin generation, fibrinolysis, and fibrin clot properties in atrial fibrillation (AF). We aimed to evaluate associations of circulating LPS with prothrombotic markers in AF patients. A total of 157 (women, 57.3%) ambulatory anticoagulant-naïve AF patients aged from 42 to 86 years were recruited. Clinical data together with serum LPS, inflammation, endothelial injury, coagulation and fibrinolysis markers, including fibrin clot permeability (Ks ) and clot lysis time (CLT), were analyzed...
April 21, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38633730/management-of-urgent-bleeding-in-patients-with-hemophilia-a-focus-on-the-use-of-emicizumab
#2
REVIEW
Víctor Jiménez-Yuste, María T Álvarez-Román, Rubén Berrueco, Santiago Bonanad, José M Calvo-Villas, Rebeca González-González, José R González Porras, Ramiro J Núñez-Vázquez, Manuel Rodríguez-López
Management of patients with hemophilia A (HA) requires the knowledge and experience of specialized health care professionals. However, these patients may need to be attended in emergencies, outside the referral hospital, where health care professionals do not know about hemophilia and/or new innovative treatments. This study aimed to develop a simple and practical algorithm that could be used in emergency situations by nonspecialized treaters in HA and bleeding with or without factor VIII (FVIII) inhibitors under emicizumab prophylaxis...
April 2024: TH Open: Companion Journal to Thrombosis and Haemostasis
https://read.qxmd.com/read/38632015/variability-of-fibrinolytic-activity-in-pregnant-patients-exposed-to-tissue-plasminogen-activator-an-in-vitro-study-utilizing-rotational-thromboelastometry
#3
JOURNAL ARTICLE
A Tran, D Katz
BACKGROUND: The investigation into the variability of fibrinolysis in obstetric patients is notably limited despite its relevance to postpartum hemorrhage. We investigate an in vitro model of fibrinolysis measured by rotational thromboelastrometry (ROTEM) in maternal blood samples with lysis stimulated by tissue plasminogen activator (tPA). METHODS: Written informed consent was obtained from 19 patients at term pregnancy during admission to the labor and delivery unit...
March 26, 2024: International Journal of Obstetric Anesthesia
https://read.qxmd.com/read/38630057/identifying-biochemical-constituents-involved-in-the-mycosynthesis-of-zinc-oxide-nanoparticles
#4
JOURNAL ARTICLE
Nathan G Brady, Shamus L O'Leary, Winson Kuo, Brett R Blackwell, Philip M Mach, John Watt, George D Bachand
Filamentous fungi are known to secrete biochemicals that drive the synthesis of nanoparticles (NPs) that vary in composition, size, and shape; a process deemed mycosynthesis. Following the introduction of precursor salts directly to the fungal mycelia or their exudates, mycosynthesis proceeds at ambient temperature and pressure, and near neutral pH, presenting significant energy and cost savings over traditional chemical or physical approaches. The mycosynthesis of zinc oxide (ZnO) NPs by various fungi exhibited a species dependent morphological preference for the resulting NPs, suggesting that key differences in the biochemical makeup of their individual exudates may regulate the controlled nucleation and growth of these different morphologies...
April 17, 2024: Nanoscale
https://read.qxmd.com/read/38625831/plasma-tissue-factor-pathway-inhibitor-levels-in-coronavirus-disease-2019-patients-a-systematic-review-and-meta-analysis
#5
JOURNAL ARTICLE
Saeed Hassani, Mohammad Sayyadi, Amir Almasi-Hashiani
UNLABELLED: Studies have suggested a relationship between tissue factor pathway inhibitor (TFPI) and coronavirus disease 2019 (COVID-19) severity. However, there is inconsistency in the findings of the studies. To enhance comprehension of this relationship, a meta-analysis was conducted. PubMed, Web of Science, and Scopus databases were searched to identify eligible studies. The mean difference was employed as effect measures and the standardized mean difference (SMD) and the 95% confidence interval (CI) were utilized as a summary statistic...
April 5, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38625829/efficacy-of-emicizumab-therapy-in-two-adult-patients-with-type-3-von-willebrand-disease
#6
JOURNAL ARTICLE
Frederick Ian LeMaistre, Elaine Chiang, Michael B Streiff, Jennifer C Yui
Type 3 von Willebrand disease (T3VWD) is a rare inherited bleeding disorder caused by the absence of von Willebrand factor (VWF). The traditional treatment for T3VWD has been VWF concentrates, but their effectiveness may be limited due to the development of alloantibodies. Emicizumab, a bispecific mAb, has shown promise in treating hemophilia A and is being studied as prophylaxis for T3VWD. In this case series, two patients with T3VWD received emicizumab prophylaxis and experienced a significant reduction in bleeding episodes and improved quality of life with fewer healthcare encounters...
March 27, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38601750/purification-and-characterization-of-a-new-pro-coagulant-protein-from-iranian-echis-carinatus-venom
#7
JOURNAL ARTICLE
Sayeneh Khodadadi, Hadi Rabiei, Soroush Sardari, Hosein Mahboudi, Mohammad Ali Bayatzadeh, Nader Vazifeh Shiran, Maryam Sardabi, Mohammad Reza Akbari Eidgahi, Hamid Madanchi, Nasser Mohammadpour
This work aimed to purify the proteins that cause blood coagulation in the venom of the Iranian Echis carinatus snake species in a comprehensive manner. Gel filtration chromatography (GFC), Ion exchange chromatography (IEC), and Size Exclusion High-Performance Liquid Chromatography (SEC-HPLC) were utilized in the purification of the coagulation factors. The prothrombin clotting time (PRCT) and SDS-PAGE electrophoresis were performed to confirm the coagulative fractions. The fraction with the shortest coagulation time was selected...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38576549/occurrence-of-fungal-microbial-contamination-in-drinking-water-of-megacity-of-karachi-pakistan-and-their-physico-chemical-control
#8
JOURNAL ARTICLE
Faisal Hussain, Iram-Us Salam, Farzana, Zaibun-Nisa Memon, Muhammad Abdullah, Ghulam Abbas, Muhammad Akbar, Alamdar Hussain, Muhammad Majeed, Kishwar Ali, Haruna Musa Moda
The water quality in Karachi (Pakistan) is uncertain due to the occurrence of fungi and other microorganisms. A total of twenty-five water samples were collected from public places, educational institutes, hospitals, water supply systems and surface water of the canal of Karachi (Pakistan). The different fungal species including Acremonium sp., Alternaria alternata, Aspergillus flavus, A. fumigatus , A. sulphureus, Cladosporium sp., Fusarium sp., Clonostachys (Gliocladium) sp., Macrophomina phaseolina , Mucor racemosus, Paecilomyces sp...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38572538/coagulation-activity-and-thrombotic-risk-following-high-volume-endurance-exercise-in-recreationally-active-cyclists
#9
JOURNAL ARTICLE
Blake E G Collins, Michael Kingsley, Brett A Gordon, Emma K Zadow, Daniel W T Wundersitz
Despite the prognostic effect of physical activity, acute bouts of high-volume endurance exercise can induce cardiac stress and post-exercise hypercoagulation associated with increased thrombotic risk. The aim of this study was to explore the effect of high-volume endurance exercise on coagulation and thrombotic activity in recreational cyclists. Thirty-four recreational cyclists completed 4.8 ± 0.3 hours cycling at 45 ± 5% of maximal power output on a bicycle ergometer. Intravenous blood samples were collected pre-exercise, immediately post-exercise, 24 and 48 hours post-exercise and analysed for brain natriuretic peptide (BNP), cardiac troponin (cTn), C-reactive protein (CRP), D-dimer, thrombin-antithrombin (TAT) complex, tissue factor (TF), tissue factor pathway inhibitor (TFPI) and TF to TFPI ratio (TF:TFPI)...
April 4, 2024: Journal of Applied Physiology
https://read.qxmd.com/read/38567679/clinical-guideline-on-reversal-of-direct-oral-anticoagulants-in-patients-with-life-threatening-bleeding
#10
JOURNAL ARTICLE
Oliver Grottke, Arash Afshari, Aamer Ahmed, Eleni Arnaoutoglou, Daniel Bolliger, Christian Fenger-Eriksen, Christian von Heymann
BACKGROUND: Anticoagulation is essential for the treatment and prevention of thromboembolic events. Current guidelines recommend direct oral anticoagulants (DOACs) over vitamin K antagonists in DOAC-eligible patients. The major complication of anticoagulation is serious or life-threatening haemorrhage, which may necessitate prompt haemostatic intervention. Reversal of DOACs may also be required for patients in need of urgent invasive procedures. This guideline from the European Society of Anaesthesiology and Intensive Care (ESAIC) aims to provide evidence-based recommendations and suggestions on how to manage patients on DOACs undergoing urgent or emergency procedures including the treatment of DOAC-induced bleeding...
May 1, 2024: European Journal of Anaesthesiology
https://read.qxmd.com/read/38565391/recent-advances-in-microplastic-removal-from-drinking-water-by-coagulation-removal-mechanisms-and-influencing-factors
#11
REVIEW
Yufeng Mao, Zuoyuan Hu, Hong Li, Huaili Zheng, Shengfa Yang, Weiwei Yu, Bingran Tang, Hao Yang, Ruixu He, Wenshu Guo, Kailai Ye, Aoguang Yang, Shixin Zhang
Microplastics (MPs) are emerging contaminants that are widely detected in drinking water and pose a potential risk to humans. Therefore, the MP removal from drinking water is a critical challenge. Recent studies have shown that MPs can be removed by coagulation. However, the coagulation removal of MPs from drinking water remains inadequately understood. Herein, the efficiency, mechanisms, and influencing factors of coagulation for removing MPs from drinking water are critically reviewed. First, the efficiency of MP removal by coagulation in drinking water treatment plants (DWTPs) and laboratories was comprehensively summarized, which indicated that coagulation plays an important role in MP removal from drinking water...
March 31, 2024: Environmental Pollution
https://read.qxmd.com/read/38563414/pharmacokinetics-pharmacodynamics-and-safety-of-fesomersen-a-novel-antisense-inhibitor-of-factor-xi-in-healthy-chinese-japanese-and-caucasian-volunteers
#12
JOURNAL ARTICLE
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
The inhibition of coagulation factor XI (FXI) presents an attractive approach for anticoagulation as it is not expected to increase the risk of clinically relevant bleeding and is anticipated to be at least as effective as currently available anticoagulants. Fesomersen is a conjugated antisense oligonucleotide that selectively inhibits the expression of FXI. The article describes three clinical studies that investigated the safety, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of fesomersen after subcutaneous (s...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38562115/-not-available
#13
JOURNAL ARTICLE
Andreas Tiede, Sophie Susen, Ton Lisman
Acquired bleeding disorders can develop in previously healthy people irrespective of age or gender but are particularly common in patients with certain underlying conditions. Here, we review recent advances in the management of acquired haemophilia A (AHA), acquired von Willebrand syndrome (AVWS), and patients with hemostatic abnormalities due to chronic liver disease (CLD). Patients with AHA can now benefit from prophylaxis with emicizumab, a therapeutic antibody that mimics the function of activated coagulation factor VIII...
April 2, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38560156/particulate-matter-reduction-efficiency-analysis-of-sprinkler-system-as-targeted-control-measures-for-construction-activity
#14
JOURNAL ARTICLE
Young-Bog Ham, Daniel Cheriyan, Hong-Uk Kim, Jae-Goo Han, Young Hyun Kim, P R Janani Priyanka, Jae-Ho Choi
Air pollution caused by the construction industry in the form of particulate matter (PM) has increased to an alarming level. The effects on the health of construction workers are found to be hazardous despite the current advancement in construction methods and practices. In particular, the efficiency of existing control measures for reducing PM from various construction activities has not been improved to the desired level. This study investigated the factors that influence the efficiency of a sprinkler system-based control measure when water spraying and dust suppressant solutions are used...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38558535/pharmacokinetics-pharmacodynamics-and-safety-of-frunexian-in-healthy-chinese-volunteer-adults-a-randomized-dose-escalation-phase-i-study
#15
JOURNAL ARTICLE
Jia-Yu Zhang, Zou-Rong Ruan, Bo Jiang, Dan-Dan Yang, Jia-Ying Wang, Yin Hu, Yong-Rui Wang, Yan-Mei Wang, Yun-Fei Lin, Ling-Ling Wang, Hong-Gang Lou
The purpose of this study was to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of frunexian (formerly known as EP-7041 and HSK36273) injection, a small molecule inhibitor of activated coagulation factor XI (FXIa), in healthy Chinese adult volunteers. This study was a randomized, placebo- and positive-controlled, sequential, ascending-dose (0.3/0.6/1.0/1.5/2.25 mg/kg/h) study of 5-day continuous intravenous infusions of frunexian. Frunexian administration exhibited an acceptable safety profile with no bleeding events...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38547693/reduced-plasma-factor-x-is-associated-with-a-lack-of-response-to-recombinant-activated-factor-vii-in-patients-with-hemophilia-a-and-inhibitor-but-does-not-impair-emicizumab-driven-hemostasis-in-vitro
#16
JOURNAL ARTICLE
Koji Yada, Natsume Fujitate, Kenichi Ogiwara, Tetsuhiro Soeda, Takehisa Kitazawa, Keiji Nogami
BACKGROUND: The hemostatic effect of recombinant (r) factor (F)VIIa after repetitive intermittent administration may be attenuated in patients with hemophilia A (PwHA) with inhibitors (PwHAwI) creating a clinically unresponsive status, although mechanism(s) remain to be clarified. In patients receiving prophylaxis treatment with emicizumab, concomitant rFVIIa is sometimes utilized in multiple doses for surgical procedures or breakthrough bleeding. AIM AND METHODS: We identified 'unresponsiveness' to rFVIIa, based on global coagulation function monitored using rotational thromboelastometry (ROTEM) in 11 PwHAwI and 5 patients with acquired HA, and investigated possible mechanisms focusing on the association between plasma FX levels and rFVIIa-mediated interactions...
March 22, 2024: Thrombosis Research
https://read.qxmd.com/read/38540863/a-stochastic-frontier-approach-to-study-the-relationship-between-the-hygienic-quality-of-bulk-tank-sheep-milk-and-technical-efficiency-of-the-coagulation-process
#17
JOURNAL ARTICLE
Lorena Jiménez, José M Perea, Javier Caballero-Villalobos, Elena Angón, Alessio Cecchinato, Nicolò Amalfitano, Bonastre Oliete, Ramón Arias
Sheep milk from local breeds is important for the production of high-quality cheeses throughout the Mediterranean region, such as Manchego cheese in Spain. To maintain sustainable and efficient production, it is necessary to reach a better understanding of how the composition and hygiene of the milk affect the coagulation process, with the aim of optimizing production yield. This study implemented a stochastic production frontier function to estimate the potential production of curd and efficiency using data from the four seasons of a study of 77 Manchega sheep farms...
March 13, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38531053/predictive-parameters-for-spontaneous-joint-bleeding-during-emicizumab-prophylaxis
#18
JOURNAL ARTICLE
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Emicizumab is approved for prophylaxis of patients with hemophilia A (HA). Despite its efficacy in reducing bleeding, a few patients on emicizumab still experience hemarthrosis, but no tool is yet available to identify those at higher risk of spontaneous joint bleeding. To evaluate whether laboratory measurements (global coagulation assays and emicizumab concentration) and/or arthropathy scores can distinguish patients at higher risk of spontaneous joint bleeding while on emicizumab prophylaxis. Thrombin generation assay (TGA) was assessed upon the addition of tissue factor and synthetic phospholipids...
March 26, 2024: Blood Advances
https://read.qxmd.com/read/38506302/a-multi-constituent-model-for-assessing-the-effect-of-impeller-shroud-on-the-thrombosis-potential-of-a-centrifugal-blood-pump
#19
JOURNAL ARTICLE
Shen Lv, Zhi-Peng He, Guang-Mao Liu, Sheng-Shou Hu
Centrifugal blood pumps can be used for treating heart failure patients. However, pump thrombosis has remained one of the complications that trouble clinical treatment. This study analyzed the effect of impeller shroud on the thrombosis risk of the blood pump, and predicted areas prone to thrombosis. Multi-constituent transport equations were presented, considering mechanical activation and biochemical activation. It was found that activated platelets concentration can increase with shear stress and adenosine diphosphate(ADP) concentration increasing, and the highest risk of thrombosis inside the blood pump was under extracorporeal membrane oxygenation (ECMO) mode...
March 20, 2024: International Journal of Artificial Organs
https://read.qxmd.com/read/38499191/prophylactic-treatment-of-children-with-hemophilia-in-sweden
#20
JOURNAL ARTICLE
Rolf Ljung
Hemophilia A/B are caused by deficiency or lack of coagulation factors VIII (FVIII) or factor IX (FIX), respectively, in plasma. A person with hemophilia develops bleeding in the joints and muscles at an early age, which, if left untreated, leads to early arthropathy. Preventive treatment can be achieved by regular (prophylactic) administration of FVIII/FIX. In 1958, this was implemented on a small scale in Sweden with FVIII in patients with severe hemophilia A, and in those with hemophilia B in 1972 when FIX became available...
March 18, 2024: Seminars in Thrombosis and Hemostasis
keyword
keyword
71742
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.